From 1963 to 2026, Sarawak transformed from a medically underserved territory into an international clinical research hub, conducting global first-in-human cancer trials and achieving 73% clinic digitalisation while pursuing health autonomy under MA63 despite persistent rural infrastructure challenges.
As of 2025, Sarawak General Hospital’s recognition and selection for Asia Pacific first-in-human trials marks a milestone for Sarawak, highlighting its emergence as a credible research hub, enhancing patient access, talent retention, and international collaboration.